Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.

Wakabayashi H, Takakura N, Yamauchi K, Tamura Y.

Clin Vaccine Immunol. 2006 Feb;13(2):239-45.

2.
3.

Reduction of concanavalin A-induced expression of interferon-gamma by bovine lactoferrin in feline peripheral blood mononuclear cells.

Kobayashi S, Sato R, Inanami O, Yamamori T, Yamato O, Maede Y, Sato J, Kuwabara M, Naito Y.

Vet Immunol Immunopathol. 2005 May 1;105(1-2):75-84.

PMID:
15797477
4.

Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.

Lorant T, Krook H, Wilton J, Olausson M, Tufveson G, Korsgren O, Johnsson C.

Xenotransplantation. 2003 Jul;10(4):311-24.

PMID:
12795680
5.

Protection against infections by oral lactoferrin: evaluation in animal models.

Teraguchi S, Wakabayashi H, Kuwata H, Yamauchi K, Tamura Y.

Biometals. 2004 Jun;17(3):231-4. Review.

PMID:
15222470
6.

Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.

Iigo M, Alexander DB, Long N, Xu J, Fukamachi K, Futakuchi M, Takase M, Tsuda H.

Biochimie. 2009 Jan;91(1):86-101. doi: 10.1016/j.biochi.2008.06.012. Epub 2008 Jun 27.

PMID:
18634843
7.

Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis.

Kuhara T, Tanaka A, Yamauchi K, Iwatsuki K.

Br J Nutr. 2014 May 28;111(10):1801-10. doi: 10.1017/S0007114513004315. Epub 2014 Jan 28.

PMID:
24472388
8.

The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice.

Sfeir RM, Dubarry M, Boyaka PN, Rautureau M, Tomé D.

J Nutr. 2004 Feb;134(2):403-9.

9.

Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I.

Gut. 1997 Dec;41(6):793-800.

10.

Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children.

Cherñavsky AC, Paladino N, Rubio AE, De Biasio MB, Periolo N, Cuarterolo M, Goñi J, Galoppo C, Cañero-Velasco MC, Muñoz AE, Fainboim H, Fainboim L.

Hum Immunol. 2004 Jul;65(7):683-91.

PMID:
15301856
11.
12.

Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

Wang WP, Iigo M, Sato J, Sekine K, Adachi I, Tsuda H.

Jpn J Cancer Res. 2000 Oct;91(10):1022-7.

PMID:
11050473
13.

Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control.

Vossenkämper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, Pfeffer K, Alber G, Lochner M, Förster I, Liesenfeld O.

Eur J Immunol. 2004 Nov;34(11):3197-207.

14.

Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis.

Iigo M, Shimamura M, Matsuda E, Fujita K, Nomoto H, Satoh J, Kojima S, Alexander DB, Moore MA, Tsuda H.

Cytokine. 2004 Jan 7;25(1):36-44.

PMID:
14687584
16.

Expression of cytokine mRNAs in mice cutaneously exposed to formaldehyde.

Xu B, Aoyama K, Takeuchi M, Matsushita T, Takeuchi T.

Immunol Lett. 2002 Oct 21;84(1):49-55.

PMID:
12161283
17.

Cytokine gene expression in autoimmune thyroiditis in BioBreeding/Worcester rats.

Blüher M, Krohn K, Wallaschofski H, Braverman LE, Paschke R.

Thyroid. 1999 Oct;9(10):1049-55.

PMID:
10560963
18.

Bovine lactoferrin: benefits and mechanism of action against infections.

Yamauchi K, Wakabayashi H, Shin K, Takase M.

Biochem Cell Biol. 2006 Jun;84(3):291-6. Review.

PMID:
16936799
19.

Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine.

Kuhara T, Yamauchi K, Tamura Y, Okamura H.

J Interferon Cytokine Res. 2006 Jul;26(7):489-99.

PMID:
16800788
20.

Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.

Vinderola G, Perdigón G, Duarte J, Farnworth E, Matar C.

Cytokine. 2006 Dec;36(5-6):254-60. Epub 2007 Mar 23.

PMID:
17363262
Items per page

Supplemental Content

Write to the Help Desk